drugset / Trial / NCT01197235

Effect of Darbepoetin in Contrast-induced Nephropathy

NCT01197235

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether the drug that produce red blood cells is effective in the prevention of kidney dysfunction after coronary angiography in patients with chronic kidney disease.

Timeline

Start
2009-05
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Darbepoetin alfa Protein / enzyme biologic 1.5 ug/kg

Indications